HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

Completed · Phase 2

Conditions studied: Sarcopenia, Muscle Weakness, Frailty

In brief

The purpose of this study is to determine the relationship of deficiencies in testosterone and growth hormone to loss of muscle mass (sarcopenia) and functional impairment during aging and whether there is an interaction of these two hormone systems in maintaining normal skeletal muscle mass and physical function.

Key facts

Study ID

NCT00183040

Run by

National Institute on Aging (NIA)

People needed

108

Starts

2002-09-01

Expected to finish

2007-02-01

Last updated by the study team

2009-06-02

Who can join

Age: 65 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men who are 65-90 years of age
• Total serum IGF-1 (insulin-like growth factor) in the lower tertile for adults (56-167 ug/dl)
• Total serum testosterone of 150-550 ng/dL

You may not qualify if…

• BMI (Body Mass Index) 35 kg/m2 or greater
• Weight instability (>3% change in prior 3 months)
• Daily intake of total kilocalories less than or equal to 0.8X the RDA and intake of protein between 0.8 and 1.4 g/kg/day inclusive
• Acute illness in the prior 30 days
• Resistance training (wt lifting) in the past 12 months
• Vigorous aerobic sports (Competing as a Master athlete in the prior 5 years; weekly swimming, racquet ball, cycling, tennis, in preceding 12 months)
• Use of an anabolic agent (androgen, androgen precursor, rhGH, etc) in the preceding 12 months
• Use of medications that might affect amino acid metabolism (e.g. beta-adrenergic blockers, beta-agonists, Ca2+ channel blockers, corticosteroids)
• Fasting sugar greater than or equal to 126 mg/dl or diabetes requiring Rx
• History of benign intracranial hypertension
• Heart failure, active angina, or myocardial infarction in the prior 6 months or history of aortic stenosis
• Uncontrolled hypothyroidism or hyperthyroidism
• Rheumatoid arthritis, cirrhosis or active hepatitis
• History of carpal tunnel syndrome
• Prior cancer other than squamous or basal cell carcinoma of the skin
• Sleep apnea or severe chronic lung disease
• Anticoagulation with heparin or coumadin
• Blood pressure not controlled with medication to <180/95 mm Hg
• Calculated creatinine clearance <50 cc/min
• Serum prostatic antigen >4.0 or American Urological Association score greater than or equal to 8
• Hematocrit greater than or equal 52%, or ALT >1.5X ULN
• Failure to pass a modified Bruce treadmill stress test
• Severe disability limiting strength or physical function testing
• Dementia or cognitive impairment affecting a subject's ability to provide informed consent

Where it is running

• Tufts University — Boston, Massachusetts, United States
• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.